Shira Huberfeld is a corporate associate and a member of the firm’s Mergers & Acquisitions Group.
Ms. Huberfeld joined Debevoise in 2019. She ...
Read Full Biography
- Five Arrows, the alternative assets arm of Rothschild & Co., in its acquisition of a majority stake in n2y, a provider of comprehensive, SaaS-based solutions for students with unique learning challenges.
- Morgan Stanley Capital Partners in its acquisition of Allstar Services and RowCal.
- Mitsui in the formation of the Blue Water Alliance, a joint venture in partnership with Olin Corporation.
- Pernod Ricard in its acquisition of a majority stake in Código 1530 Ultra Premium and Prestige Tequila.
- EQT Exeter, a purpose-driven global investment organization, in its acquisition of Redwood Capital Group, an asset manager in the multifamily residential property space.
- TA Associates, in its acquisition of TouchTunes, an in-venue, interactive music and entertainment platform, from funds advised by Searchlight and Newlight.
- Carlyle, as majority owner of Syniverse, in the financing aspects of Syniverse’s $2.85 billion merger, later terminated, with special purpose acquisition company M3-Brigade Acquisition II Corp. resulting in Syniverse becoming a publicly traded company.
- Clayton, Dubilier & Rice in the financing aspects of its $6 billion acquisition and subsequent combination of Fort Dearborn and Multi-Color Corporation, to create the world's largest label solutions company.
- Clayton, Dubilier & Rice in the financing aspects of its $3.7 billion take-private acquisition of UDG Healthcare.
- Precision Medical Group in its investment from funds managed by Blackstone.
- Stone Point Capital in its investment in Lone Wolf Technologies, the North American leader in residential real estate software.
- Aveva Group, a global leader in industrial software, in its $5 billion acquisition of OSIsoft.
- Morgan Stanley Capital Partners and Pathway Vet Alliance in the $2.7 billion sale of a majority stake in Pathway to TSG Consumer Partners.
- LeapFrog Investments in its investment in MedGenome, a leading genetic diagnostics, research and data company focused on expanding access for populations in South Asia and other emerging markets, with operations in the U.S., India, Canada and Singapore.
- Harvard Law School, 2019, J.D.
- Yeshiva University, 2016, B.A.